![Alana McNulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alana McNulty
Director/Board Member at
JANUX THERAPEUTICS, INC.
Net worth: 36 475 $ as of 30/05/2026
Profile
Alana B. McNulty is currently an Independent Director at Janux Therapeutics, Inc. since 2021, a Director at Lipidio Pharmaceuticals, Inc. since 2023, and Chief Business Officer at eFFECTOR Therapeutics Operations, Inc. since 2021.
Former roles include Independent Director at NKGen Biotech, Inc. from 2023 to 2024, General Manager & Head-Corporate Development at Advanced Tissue Sciences, Inc. from 1991 to 1998, Associate-BioSciences Group at The Bear Stearns Cos., Inc., Chief Financial Officer & Vice President-Finance at Elitra Pharmaceuticals, Inc. from 1998 to 2003, Chief Financial Officer & Vice President-Finance at BrainCells, Inc. from 2004 to 2011, Chief Financial Officer at Lumena Pharmaceuticals, Inc. from 2012 to 2014, Chief Financial Officer at Excaliard Pharmaceuticals, Inc. in 2011, and Chief Business Officer at eFFECTOR Therapeutics, Inc. from 2020 to 2022.
Education includes undergraduate studies at the University of California, Santa Barbara and an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/02/2026 | 2,500 ( 0% ) | 36 475 $ | 30/05/2026 |
Alana McNulty active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 06/09/2021 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Corporate Officer/Principal | 06/01/2021 |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Director/Board Member | 31/01/2023 |
Former positions of Alana McNulty
| Companies | Position | End |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Director of Finance/CFO | 30/11/2020 |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Director of Finance/CFO | 31/10/2014 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Director of Finance/CFO | 31/10/2011 |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Director of Finance/CFO | 31/12/2010 |
Training of Alana McNulty
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
32
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Advanced Tissue Sciences, Inc.
 Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
The Bear Stearns Cos., Inc.
 The Bear Stearns Cos., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage services | Finance |
Elitra Pharmaceuticals, Inc.
 Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipidio Pharmaceuticals, Inc.
Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Alana McNulty
